All Posts By

Allison Sit

Dec 02
Love0

Incorporating Acneceuticals: JDD Podcast

By Medical Dermatology

acneceuticals

Acneceuticals are a new category of acne products on the market. These are over-the-counter actives that can be used on their own or as adjunctive therapies to keep acne-prone skin clear.

In this JDD Podcast, host and ODAC Conference Co-Chair Adam Friedman, MD, FAAD, is joined by acne researcher Hilary Baldwin, MD, FAAD, to share highlights from her latest Journal of Drugs in Dermatology supplement on the real-world use of acneceuticals. Listen as they share an algorithm that guides product picks and delve into skincare science for acne. Hear clinical pearls and find out why, when treating acne, you may want to give a second glance at the skin care aisle.

In addition to her credibility as a researcher, Dr. Baldwin is also known for her engaging lectures chock-full of practical guidance. Register for ODAC and attend Dr. Baldwin’s medical dermatology sessions:

  • The 2025 Acne Treatment Landscape: Prescription, OTC, and Adjunctive Therapies
  • Integrating Cosmeceuticals With Prescription Therapies for Barrier Repair
  • Treating Keloids With Confidence: Evidence-Based Approaches for Dermatologists

Episodes of the JDD Podcast are available on iTunes, Spotify, Stitcher and TuneIn.

 

Nov 24
Love0

Pyoderma Gangrenosum and Sweet Syndrome: ODAC Interview

By ODAC Sessions

neutrophilic dermatoses

Neutrophilic dermatoses aren’t commonly addressed in dermatologic continuing education, yet understanding how to diagnose these dermatoses is important. An accurate diagnosis could reveal an underlying autoinflammatory disease.

Watch this Next Steps in Derm video interview with Anthony Fernandez, MD, PhD, FAAD, from ODAC 2025, where he addresses the most common neutrophilic dermatoses that a dermatologist will see in clinic: pyoderma gangrenosum and Sweet syndrome.

Dr. Fernandez shares criteria for making an accurate pyoderma gangrenosum diagnosis. Learn treatment options and why wound healing expertise is key when managing these patients. Find out why Dr. Fernandez says treating Sweet syndrome may be easier than treating pyoderma gangrenosum. Plus hear about a late-onset, autoinflammatory disease that may be an underlying disease in certain patients who present with rashes that are consistent with Sweet syndrome.

Register for ODAC 2026 for more medical dermatology updates.

Nov 14
Love0

Patient Buzz: Skin Care After GLP-1 Weight Loss

By Patient Care

skin care after GLP-1 weight loss

GLP-1 agonists are a popular method of losing weight, which is leading to patient questions about skin care after GLP-1 weight loss. In this Next Steps in Derm Patient Buzz, Heather Woolery-Lloyd, MD, FAAD, outlines skincare ingredients that can address skin laxity and textural changes from losing a significant amount of weight. She also addresses in-office procedures and when to refer a patient to a plastic surgeon. Find out her approach with patients who are experiencing significant weight loss and why it’s important to set realistic expectations with patients.

GLP-1 agonists are increasingly used by dermatologists to address comorbidities from inflammatory skin diseases. For more on their dermatologic use, attend the ODAC session, “GLP-1 Agonists in Cutaneous Medicine: Rapid-Fire Insights on Comorbidities, Safety, and Aesthetic Considerations – Panel Discussion”. Register today!

Nov 05
Love0

Improve Quality of Life in Patients With Hyperhidrosis

By Medical Dermatology

hyperhidrosis

Hyperhidrosis affects nearly 400 million people worldwide, yet it’s often misunderstood and underdiagnosed. In fact, 27% of adults never receive a diagnosis, according to the International Hyperhidrosis Society. The condition greatly impacts a person’s quality of life: People with excessive sweating face nearly three times the risk of anxiety and depression.

November is Hyperhidrosis Awareness Month. Let’s bring excessive sweating out of hiding and help people find understanding and treatment.

Join us for the ODAC Pre-Conference Virtual Symposium on Tuesday, November 11, where dermatologist Dr. Angela Lamb will share strategies and new tools to improve quality of life in patients with excessive sweating. You’ll also experience case-based sessions on chronic itch, hidradenitis suppurativa, and pediatric alopecia areata. Registration is complimentary – plus you can earn CME!

We hope to see you at this interactive event that’s sure to provide you with practical takeaways you can immediately apply in clinic.

Improve your knowledge and provide hyperhidrosis patients with hope and healing.

Oct 29
Love0

Growing a Dermatology Practice: ODAC Interview

By ODAC Sessions

growing a dermatology practice

A service-oriented culture can help grow a dermatology practice, according to ODAC faculty Robyn Siperstein, MD, FAAD. Dr. Siperstein credits her workplace culture for her practice’s expansion to more than 100 staff members at two locations.

Check out this interview with Next Steps in Derm from ODAC 2025 where Dr. Siperstein shares her early leadership lessons and how this culture permeates her office from the top down. Go to school on Dr. Siperstein’s signature moves in growing a dermatology practice through service. Plus learn how to make each patient interaction one that expresses value.

Are you a wannabe practice owner? Register for ODAC 2026 and attend Dr. Ronda S. Farah’s session on what it takes to open a dermatology practice.

Oct 24
Love0

Vulvar Dermatoses: ODAC Pearls from Dr. Christina Kraus

By ODAC Sessions

vulvar dermatoses

At the 2025 ODAC Dermatology Conference, Christina Kraus, MD, FAAD, reviewed systemic treatment options for refractory vulvar inflammatory dermatoses, such as lichen sclerosus (LS), lichen planus (LP), and lichen simplex chronicus (LSC). While most cases respond to potent topical corticosteroids, systemics may be needed for severe or pre-scarring disease, recalcitrant symptoms, or when topical use is limited by side effects or patient preference.

Key takeaways:

  • When to consider systemics: severe/refractory disease, extragenital involvement, prevention of scarring, poor quality of life, or steroid-sparing needs.
  • Common agents: oral retinoids, methotrexate, mycophenolate mofetil, adalimumab; systemic steroids mainly for short-term use.
  • Emerging options: IL-23 inhibitors and JAK inhibitors show promise but require further study.
  • Condition-specific notes:
    • LS: maintenance therapy critical to prevent scarring/malignancy.
    • LP: erosive type often requires systemic therapy; overlap with LS should be considered.
    • LSC: no scarring risk but major quality-of-life impact; systemic immunosuppressants, dupilumab, or neuropathic agents may help.
  • Approach: shared decision-making, patient counseling, monitoring, and collaboration with gynecology/rheumatology as appropriate.

Bottom line: Systemic agents can expand therapeutic options for vulvar dermatoses when topicals fail, but careful patient selection, counseling, and ongoing study of newer therapies are essential.

This session summary was written by Kala Hurst, DO, and published on Next Steps in Derm.

Register for ODAC 2026 for more medical dermatology updates.

Oct 17
Love0

What’s New in Rosacea: Interview with Dr. Adam Friedman

By ODAC Sessions

rosacea

ODAC Co-Chair Adam Friedman, MD, FAAD, says he’s changed the way he approaches rosacea due to some nuances in recently published studies.

Watch this Next Steps in Derm video interview with Dr. Friedman from ODAC 2025 where he addresses what’s new in the understanding of rosacea triggers. Does current research support the longstanding guidance to avoid coffee? Plus learn Dr. Friedman’s top strategies for managing rosacea and find out about three recently FDA-approved rosacea therapies.

Don’t miss Dr. Friedman’s rosacea session at ODAC 2026 where he’ll address more new developments and practical approaches. Register today!

Oct 07
Love0

Patient Buzz: Eczema & Mental Health

By Medical Dermatology

eczema and mental health

In recognition of October as Eczema Awareness Month, we consider the mental health implications of eczema. In this Next Steps in Derm Patient Buzz, dermatologist and clinical psychologist Richard Fried, MD, PhD, shares what clinicians should know about eczema’s mental health impact.

Learn what mental health symptoms are common in eczema patients and how to broach the subject in your patient interactions. Find out how Dr. Fried directs his patients who are looking for help in improving their eczema-related mental health. 

Register for ODAC 2026 for the latest guidance in treating eczema and other inflammatory skin conditions.

Sep 29
Love0

The Dermatology Digest: ODAC 2025 Coverage on Prurigo Nodularis

By Media Coverage

prurigo nodularis

ODAC Conference Co-Chair Adam Friedman, MD, FAAD, spoke with The Dermatology Digest about his ODAC 2025 presentation on prurigo nodularis.

Learn what’s new in the understanding of the condition and what to consider in a differential diagnosis. Hear Dr. Friedman’s insight on the significant burden prurigo nodularis places upon patients. (It may shock you!) Plus find out about FDA-approved therapies and the two therapeutic pathways to consider combining in your treatment plan.

For more on prurigo nodularis, register for ODAC 2026 and attend Dr. Friedman’s lecture, “Prurigo Nodularis & Other Pruritic Problems”.

Sep 23
Love0

Secukinumab Therapeutic Cheat Sheet

By Medical Dermatology

secukinumab

ODAC shares practical, clinically relevant updates in medical dermatology. Our partner Next Steps in Derm shares this new cheat sheet for prescribing and managing patients on secukinumab.

Learn secukinumab’s mechanism of action and dermatologic uses. Know side effects, and warnings and precautions. Plus find out what baseline lab monitoring you should order.

The Secukinumab Therapeutic Cheat Sheet is available online and in a downloadable and printable PDF.

Register for ODAC and learn the latest in treating psoriasis, psoriatic arthritis, hidradenitis suppurativa, and other dermatologic conditions where secukinumab is a treatment option.

Close Menu